EP Patent

EP2119449A1 — Hgf preparation

Assigned to Kringle Pharma Inc · Expires 2009-11-18 · 16y expired

What this patent protects

The present invention relates to an HGF preparation comprising HGF and purified sucrose. The HGF preparation is characterized by being stable even after a long-term storage.

USPTO Abstract

The present invention relates to an HGF preparation comprising HGF and purified sucrose. The HGF preparation is characterized by being stable even after a long-term storage.

Drugs covered by this patent

Patent Metadata

Patent number
EP2119449A1
Jurisdiction
EP
Classification
—
Expires
2009-11-18
Drug substance claim
No
Drug product claim
No
Assignee
Kringle Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.